OptimizeRx Corporation (OPRX)Healthcare | Health Information Services | Waltham, United States | NasdaqCM
6.50 USD
-0.05
(-0.763%) ⇩
(July 14, 2026, 10:02 a.m.
EDT)
|
Hot Take ↕ | July 11, 2026, 3:16 a.m. EDT
The investment case for OptimizeRx is currently defined by a stark disconnect between deteriorating operational reality and speculative market pricing. Fundamentally, the company is struggling with a -9.5% revenue decline and missed earnings estimates, while the balance sheet shows debt slightly exceeding cash reserves. Although the forward P/E looks attractive at under 6x, this is a classic value trap where the market has already priced in the growth failure; the trailing P/E of 17x confirms that past profitability was not sustainable. The short-term outlook remains neutral-to-slightly-bearish despite the recent price recovery. While the stock has rallied from its lows, it is still trading significantly below its 200-day average, indicating the broader market has not yet accepted the new lower reality. The statistical forecast offers only a weak lean upward, which aligns with the lack of a clear catalyst for a sustained rally. Options activity tells a story of hope rather than conviction. Traders are buying deep out-of-the-money calls expiring in September, betting on a sharp, temporary surge. This is typical behavior for a distressed small-cap stock awaiting a specific news event, but it does not reflect a high-conviction belief in the company's long-term survival or growth. With no dividend to provide income and a history of volatile, declining performance, the risk-reward profile favors waiting for clearer signs of stabilization before adding capital. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.185662 |
| AutoETS | 0.185664 |
| AutoTheta | 0.185886 |
| MSTL | 0.194762 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 38% |
| H-stat | 0.68 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.088 |
| Excess Kurtosis | -0.94 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 18.298 |
| Revenue per Share | 5.763 |
| Market Cap | 121,972,992 |
| Trailing P/E | 18.06 |
| Forward P/E | 5.95 |
| Beta | 1.08 |
| Profit Margins | 6.37% |
| Website | https://www.optimizerx.com |
As of July 11, 2026, 3:16 a.m. EDT: Speculators are positioning for a significant upside move, evidenced by massive open interest in out-of-the-money calls (strikes $10 and $15) relative to puts. However, this bullish sentiment is heavily skewed toward expiration in September, suggesting a speculative bet on a seasonal or event-driven spike rather than a sustained trend. The lack of put activity indicates minimal hedging against downside risk.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.49498844 |
| Address1 | 260 Charles Street |
| Address2 | Suite 302 |
| All Time High | 99.18 |
| All Time Low | 0.6 |
| Ask | 8.35 |
| Ask Size | 2 |
| Audit Risk | 10 |
| Average Daily Volume10 Day | 390,360 |
| Average Daily Volume3 Month | 471,090 |
| Average Volume | 471,090 |
| Average Volume10Days | 390,360 |
| Beta | 1.076 |
| Bid | 4.72 |
| Bid Size | 2 |
| Board Risk | 1 |
| Book Value | 6.839 |
| City | Waltham |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 8 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 6.5 |
| Current Ratio | 5.37 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 6.565 |
| Day Low | 6.435 |
| Debt To Equity | 18.298 |
| Display Name | OptimizeRx |
| Dividend Date | 1,526,256,000 |
| Earnings Call Timestamp End | 1,778,617,800 |
| Earnings Call Timestamp Start | 1,778,617,800 |
| Earnings Timestamp | 1,778,616,000 |
| Earnings Timestamp End | 1,786,046,400 |
| Earnings Timestamp Start | 1,786,046,400 |
| Ebitda | 18,858,000 |
| Ebitda Margins | 0.17568001 |
| Enterprise To Ebitda | 6.706 |
| Enterprise To Revenue | 1.178 |
| Enterprise Value | 126,458,240 |
| Eps Current Year | 0.938 |
| Eps Forward | 1.092 |
| Eps Trailing Twelve Months | 0.36 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 5.528 |
| Fifty Day Average Change | 0.9720001 |
| Fifty Day Average Change Percent | 0.17583215 |
| Fifty Two Week Change Percent | -49.498844 |
| Fifty Two Week High | 22.25 |
| Fifty Two Week High Change | -15.75 |
| Fifty Two Week High Change Percent | -0.7078652 |
| Fifty Two Week Low | 4.54 |
| Fifty Two Week Low Change | 1.96 |
| Fifty Two Week Low Change Percent | 0.43171808 |
| Fifty Two Week Range | 4.54 - 22.25 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,196,260,200,000 |
| Float Shares | 14,426,777 |
| Forward Eps | 1.092 |
| Forward P E | 5.952381 |
| Free Cashflow | 11,345,375 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 132 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,782,864,000 |
| Gross Margins | 0.70039004 |
| Gross Profits | 75,183,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.12875 |
| Held Percent Institutions | 0.77919996 |
| Implied Shares Outstanding | 18,765,075 |
| Industry | Health Information Services |
| Industry Disp | Health Information Services |
| Industry Key | health-information-services |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,526,256,000 |
| Last Split Factor | 1:3 |
| Long Business Summary | OptimizeRx Corporation operates as a digital healthcare technology company. It offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers' target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, limited distribution drug information, and patient support program messaging through healthcare professionals; and media execution solutions, which deliver messages through consumer omnichannel network, including through programmatic display, programmatic connected television/over-the-top, programmatic social media, addressable television, digital out-of-home, programmatic audio, and email/direct mail. The company also offers pharmacy alerts, which flag pharmacies that have prescription medications in stock; and financial messaging solutions, which provide prescribers visibility to branded copay offers for patients directly within electronic health record systems and ePrescribing platforms. The company was founded in 2006 and is headquartered in Waltham, Massachusetts. |
| Long Name | OptimizeRx Corporation |
| Market | us_market |
| Market Cap | 121,972,992 |
| Market State | REGULAR |
| Max Age | 86,400 |
| Message Board Id | finmb_52289160 |
| Most Recent Quarter | 1,774,915,200 |
| Net Income To Common | 6,836,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 122,535,939 |
| Number Of Analyst Opinions | 5 |
| Open | 6.5 |
| Operating Cashflow | 14,384,000 |
| Operating Margins | 0.019960001 |
| Overall Risk | 5 |
| Payout Ratio | 0.0 |
| Peg Ratio | 1.61 |
| Phone | 248 651 6568 |
| Previous Close | 6.55 |
| Price Eps Current Year | 6.9296374 |
| Price Hint | 2 |
| Price To Book | 0.95043135 |
| Price To Sales Trailing12 Months | 1.1362709 |
| Profit Margins | 0.06368 |
| Quick Ratio | 5.07 |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.05000019 |
| Regular Market Change Percent | -0.7633617 |
| Regular Market Day High | 6.565 |
| Regular Market Day Low | 6.435 |
| Regular Market Day Range | 6.435 - 6.565 |
| Regular Market Open | 6.5 |
| Regular Market Previous Close | 6.55 |
| Regular Market Price | 6.5 |
| Regular Market Time | 1,784,037,734 |
| Regular Market Volume | 26,808 |
| Return On Assets | 0.05432 |
| Return On Equity | 0.0556 |
| Revenue Growth | -0.095 |
| Revenue Per Share | 5.763 |
| Sand P52 Week Change | 0.20365608 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 5 |
| Shares Outstanding | 18,765,075 |
| Shares Percent Shares Out | 0.0602 |
| Shares Short | 1,129,328 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 1,731,042 |
| Short Name | OptimizeRx Corporation |
| Short Percent Of Float | 0.0631 |
| Short Ratio | 2.48 |
| Source Interval | 15 |
| State | MA |
| Symbol | OPRX |
| Target High Price | 18.0 |
| Target Low Price | 9.0 |
| Target Mean Price | 12.4 |
| Target Median Price | 11.0 |
| Total Cash | 20,169,000 |
| Total Cash Per Share | 1.075 |
| Total Debt | 23,716,000 |
| Total Revenue | 107,345,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 0.36 |
| Trailing P E | 18.055555 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 10.5774 |
| Two Hundred Day Average Change | -4.0774 |
| Two Hundred Day Average Change Percent | -0.38548228 |
| Type Disp | Equity |
| Volume | 26,808 |
| Website | https://www.optimizerx.com |
| Zip | 2,453 |